Recommendations for the initial management of multisystem inflammatory syndrome temporally related to COVID-19, in children and adolescents

dc.creatorKohn-Loncarica, Guillermo
dc.creatorFustiñana, Ana
dc.creatorDíaz, Franco
dc.creatorJaramillo-Bustamante, Juan C.
dc.creatorGonzález-Dambrauskas, Sebastián
dc.creatorVásquez-Hoyos, Pablo
dc.creatorFernández-Sarmiento, Jaime
dc.creatorGonzález, Gustavo
dc.creatorMansur, Alejandro
dc.creatorPonce, Javier
dc.creatorJabornisky, Roberto
dc.date.accessioned2021-08-31T15:29:53Z
dc.date.accessioned2023-05-19T14:53:39Z
dc.date.available2021-08-31T15:29:53Z
dc.date.available2023-05-19T14:53:39Z
dc.date.created2021-08-31T15:29:53Z
dc.date.issued2020
dc.identifierArchivos Argententinos de Pediatría 2020;118(6):e514-e526
dc.identifierhttps://doi.org/10.5546/aap.2020.eng.e514
dc.identifierhttp://hdl.handle.net/11447/4542
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/6303608
dc.description.abstractMultisystem inflammatory syndrome temporally related to COVID-19 in children and adolescents is a clinical presentation of SARS-CoV-2 infection. It shares some features with Kawasaki disease, toxic shock, sepsis, macrophage activation syndrome, and myocarditis. Few publications have addressed its initial management, which is similar to that proposed for septic shock. This review analyzes such approach based on the characteristics typical of multisystem inflammatory syndrome related to COVID-19 in accordance with the paradigm of an "institutional practice guideline" and suggests therapeutic approach strategies, including early detection, stabilization, referral, specific treatment, and process analysis.
dc.languageen
dc.subjectCOVID-19
dc.subjectSARSCoV-2
dc.subjectMultisystem inflammatory syndrome
dc.subjectPatient care bundles
dc.subjectSepsis
dc.titleRecommendations for the initial management of multisystem inflammatory syndrome temporally related to COVID-19, in children and adolescents
dc.typeArticle


Este ítem pertenece a la siguiente institución